Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults
- PMID: 22045700
- PMCID: PMC3280125
- DOI: 10.1158/1055-9965.EPI-11-0734
Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults
Abstract
Introduction: Human papillomavirus (HPV) is an important risk factor for oropharyngeal cancer. Individuals with human immunodeficiency virus (HIV) have higher oral HPV prevalence but the risk factors for oral HPV infection are not well understood for either HIV-positive or HIV-negative individuals.
Methods: This study was nested within the Multicenter AIDS Cohort Study (MACS; men) and Women Interagency HIV Study (WIHS; women) cohorts. Exfoliated oral epithelial cells were collected from 379 HIV-positive and 266 at-risk HIV-negative individuals using a rinse and gargle with Scope mouthwash. Samples were tested for 36 types of HPV DNA using PGMY09/11 consensus primers and reverse line blot hybridization. Risk factors for oral HPV infection were explored using logistic regression with generalized estimating equations in this cross-sectional analysis.
Results: Prevalent oral HPV infection was common (34%), including HPV16 infection in 5.7% of participants. HIV-positive individuals had increased odds of prevalent oral HPV infection compared with HIV-negative individuals [adjusted OR = 2.1; 95% confidence interval (CI), 1.6-2.8]. Risk factors for prevalent oral HPV differed in HIV-positive and HIV-negative participants. Among HIV-negative individuals, higher number of recent oral sex or rimming partners were strong risk factors for prevalent oral HPV infection (each P(trend) < 0.01). In contrast, among HIV-positive individuals, lower CD4 T-cell count (P(trend) < 0.001) and higher number of lifetime sexual partners (P(trend) = 0.03) were strong risk factors.
Conclusions: Oral HPV prevalence was elevated in HIV-positive individuals after controlling for differences in cigarette smoking and sexual behavior, supporting the possibility that HIV may affect the natural history of oral HPV.
Impact: Immunosuppression may contribute to increased persistence or progression of oral HPV infection.
Figures
Similar articles
-
Natural history of anal vs oral HPV infection in HIV-infected men and women.J Infect Dis. 2013 Jul 15;208(2):330-9. doi: 10.1093/infdis/jit170. Epub 2013 Apr 17. J Infect Dis. 2013. PMID: 23596319 Free PMC article.
-
The association of medication use with clearance or persistence of oral HPV infection.Cancer Causes Control. 2016 Dec;27(12):1491-1498. doi: 10.1007/s10552-016-0826-2. Epub 2016 Nov 1. Cancer Causes Control. 2016. PMID: 27804058 Free PMC article.
-
Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults.Am J Epidemiol. 2015 Jan 1;181(1):40-53. doi: 10.1093/aje/kwu247. Epub 2014 Dec 4. Am J Epidemiol. 2015. PMID: 25480823 Free PMC article.
-
Oral human papillomavirus in healthy individuals: a systematic review of the literature.Sex Transm Dis. 2010 Jun;37(6):386-91. doi: 10.1097/OLQ.0b013e3181c94a3b. Sex Transm Dis. 2010. PMID: 20081557 Review.
-
National prevalence of oral HPV infection and related risk factors in the U.S. adult population.Oral Dis. 2012 Jul;18(5):430-41. doi: 10.1111/j.1601-0825.2011.01892.x. Epub 2012 Jan 18. Oral Dis. 2012. PMID: 22251072 Review.
Cited by
-
The etiologic spectrum of head and neck squamous cell carcinoma in young patients.Oncotarget. 2016 Oct 4;7(40):66226-66238. doi: 10.18632/oncotarget.11265. Oncotarget. 2016. PMID: 27528225 Free PMC article. Review.
-
Oral Human Papillomavirus Infection and Oral Lesions in HIV-Positive and HIV-Negative Dental Patients.J Infect Dis. 2015 Sep 1;212(5):760-8. doi: 10.1093/infdis/jiv080. Epub 2015 Feb 13. J Infect Dis. 2015. PMID: 25681375 Free PMC article.
-
Alterations of the gut microbiome in HIV infection highlight human anelloviruses as potential predictors of immune recovery.Microbiome. 2024 Oct 17;12(1):204. doi: 10.1186/s40168-024-01925-7. Microbiome. 2024. PMID: 39420423 Free PMC article.
-
Oropharynx HPV status and its relation to HIV infection.PeerJ. 2018 Mar 22;6:e4407. doi: 10.7717/peerj.4407. eCollection 2018. PeerJ. 2018. PMID: 29593938 Free PMC article.
-
HIV Modifies the Effect of Tobacco Smoking on Oral Human Papillomavirus Infection.J Infect Dis. 2020 Jul 23;222(4):646-654. doi: 10.1093/infdis/jiaa135. J Infect Dis. 2020. PMID: 32211783 Free PMC article.
References
-
- Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14(2):467–475. - PubMed
-
- Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol. 2004;31(6):744–754. - PubMed
-
- D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944–1956. - PubMed
-
- Hansson BG, Rosenquist K, Antonsson A, Wennerberg J, Schildt EB, Bladstrom A, et al. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: A population-based case-control study in southern sweden. Acta Otolaryngol. 2005;125(12):1337–1344. - PubMed
-
- Ryerson AB, Peters ES, Coughlin SS, Chen VW, Gillison ML, Reichman ME, et al. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US: 1998–2003. Cancer. 2008;113(10 Suppl):2901–2909. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 AI035042/AI/NIAID NIH HHS/United States
- U01-AI-35043/AI/NIAID NIH HHS/United States
- P30 AI082151/AI/NIAID NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- U01-HD-32632/HD/NICHD NIH HHS/United States
- U01-AI-35041/AI/NIAID NIH HHS/United States
- U01-AI-34994/AI/NIAID NIH HHS/United States
- U01 AI035041/AI/NIAID NIH HHS/United States
- U01-AI-35004/AI/NIAID NIH HHS/United States
- U01-AI-31834/AI/NIAID NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- R01 DE021395-01A1/DE/NIDCR NIH HHS/United States
- U01-AI-35039/AI/NIAID NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- R01 DE021395/DE/NIDCR NIH HHS/United States
- U01 AI035039/AI/NIAID NIH HHS/United States
- U01-AI-35042/AI/NIAID NIH HHS/United States
- U01-AI-42590/AI/NIAID NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- U01-A1-35043/PHS HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- UL1-RR025005/RR/NCRR NIH HHS/United States
- U01-AI-35040/AI/NIAID NIH HHS/United States
- U01 AI035043/AI/NIAID NIH HHS/United States
- U01-AI-34993/AI/NIAID NIH HHS/United States
- P30 AI 082151/AI/NIAID NIH HHS/United States
- U01 AI035040/AI/NIAID NIH HHS/United States
- U01-AI-34989/AI/NIAID NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous